Otto joins Bioforum from Australian specialist CRO Clinical Network Services (CNS), part of Novotech, the largest Asia-Pacific-based CRO, where he was Director of Clinical Programming and previously Director of Biometrics & IT from 2013-2019. Prior to CNS, Damsma was the Business Manager at The Centre for Integrated Preclinical Drug Development at the University of Queensland and a Business Development Officer, Queensland Clinical Trials Network (now Life Sciences Queensland). Earlier in his career, Damsma served as Director of IT/Information Management and Director of Biometrics at Astellas Pharma Europe, and Clinical Research Manager at Boehringer Ingelheim in Holland. He holds a certificate in post-doctoral information management and M.Sc. in Chemistry from the University of Amsterdam.